查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1438430

滅菌設備：市場佔有率分析、產業趨勢/統計、成長預測（2024-2029）

Global Sterilization Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2024年全球滅菌設備市場規模為89.4億美元，預計2029年將達127.7億美元，預測期（2024-2029年）年複合成長率為7.37%。

全球滅菌設備市場

COVID-19 大流行改變了醫療保健優先事項並對醫療保健管理產生了負面影響。疫情爆發之初，多個國家處於封鎖狀態。由於我們關閉與其他國家的貿易並實施旅行限制，包括治療、診斷和手術在內的醫療服務在 2020 年上半年有所下降。預防醫院感染對於 COVID-19 的臨床管理非常重要。發表於 2021 年 8 月，題為「英國第一波 COVID-19 大流行浪潮中的醫院獲得性 SARS-CoV-2 感染」。研究顯示，英國314 家醫院中感染COVID-19 的患者中有11.3 % 受感染入學後。 2020 年 5 月，這一比例增至 15.8%。因此，這次疫情影響了醫療機構的醫院感染控制能力，並顯著增加了對滅菌器的需求。由於 COVID-19 病例的增加，政府組織也在努力減少 COVID-19 的影響。例如，根據美國食品藥物管理局(USFDA) 2020 年 3 月的更新，為行業和食品藥物管理局工作人員提供了指南，以促進無菌或消毒醫療設備的快速週轉並提高COVID-19 期間在的安全性大流行期間，保持消毒器、消毒設備和空氣清淨機的供應是適當的，以幫助降低患者和醫護人員因突發公共衛生事件而接觸SARS-CoV-2病毒的風險。這就是我的意思。美國食品藥物管理局認為，在這次公共衛生緊急情況下增加滅菌器、消毒劑和空氣清淨機的供應將有助於解決這些緊迫的公共衛生問題。

隨著世界人口的增加，各種感染疾病的盛行率正在迅速增加。其中許多疾病需要醫療介入或手術。手術中使用的儀器和設備必須是無菌的。此外，受感染的設備還可能造成疾病的交叉感染。根據美國整形外科醫師協會2020年全國整形外科統計數據，2020年美國進行了2,314,720例整容手術，2019年進行了2,678,302例手術。此外，2020 年和 2019 年美國進行的重組手術總數分別為 6,878,486 例和 6,652,591 例。由於這些手術需要無菌器械，預計未來幾年市場將顯著成長。

這些因素增加了對消毒設備的需求，以防止感染疾病的進一步傳播。製藥公司進入市場也是市場成長的主要因素。然而，這些設備的核准和製造的嚴格監管標準，以及某些設備中使用的化學消毒劑對眼睛和皮膚的潛在損害，已經減緩了市場的發展，抑制了成長。

滅菌設備市場趨勢

高溫滅菌器佔據市場主導地位

高溫裝置是應用最廣泛、最可靠的滅菌裝置。高溫滅菌通常對患者、工作人員和環境無害，並且能夠非常有效地殺死細菌。它還具有成本效益，因為它能深入滲透到醫療設備中，並且與其他滅菌設備相比成本更低。這些因素促成了該細分市場的市場主導地位。高溫滅菌器又細分為蒸氣滅菌器和乾式滅菌器。

幾種外科手術的增加可能會促進該過程中使用的手術器械的高溫滅菌，從而促進該細分市場的成長。根據美國關節置換登記處的 2020 年年度報告，2012 年至 2019 年間，美國進行了 1,897,050 例初次和重新置換髖關節和膝關節置換術。此外，2012 年至 2019 年間，美國進行了約 995,410 例全膝關節置換術和 625,097 例全髖關節置換術。

根據美國代謝和減肥外科學會的統計數據，2019 年僅美國就進行了約 256,000 例手術，2018 年為 252,000 例。這些統計數據顯示減重手術數量的增加，推動了整體市場的成長。

此外，該領域新產品的推出可能會推動市場成長。例如，2020年5月，Esco推出了具有高溫滅菌功能的Esco CelCulture CO2培養箱（CCL-HHS）。事實證明，這可以有效殺死可能污染工作空間的抗藥性真菌、細菌孢子和植物細胞。因此，預計這些因素將在預測期內推動該行業的成長。

北美將經歷最快的成長

北美滅菌設備市場出現了積極成長，預計在預測期內將出現顯著成長。交叉污染和醫院感染風險的增加、手術數量的增加、大型市場參與者的存在以及研發程序的增加預計將推動該地區的市場。預計美國將主導北美市場。

根據美國疾病管制與預防中心發布的 2020 年 HAI 進展報告執行摘要，美國大約每 31 名患者美國就有 1 人至少有一種院內感染，該國醫療機構的患者照護這凸顯了改進實踐的必要性。因此，該國的醫院感染增加了對適當衛生維護和消毒的需求，包括及時更換醫院窗簾。

此外，老年人更容易接受手術且免疫力較低，這使他們面臨更高的感染疾病風險。根據《2019年世界老化報告》，預計該國老年人口將從2019年的5,334萬增加到2050年的8,381.3萬，這將增加感染疾病的發生率，並有助於市場成長。

該領域的技術進步也正在推動市場。例如，2020 年 9 月，Midmark Corporation 推出了新的滅菌器資料記錄器和更新的 Midmark M3 蒸氣滅菌器，為美國牙科診所的器械處理帶來了速度、簡單性和合規性。

因此，對醫療設備和其他儀器的需求激增，增加了對滅菌設備的需求。

滅菌器產業概況

大多數滅菌設備是由世界各地的公司製造的。擁有更多研究經費和更好分銷系統的市場領導已經確立了自己的市場地位。主要市場參與者包括 Getinge AB、Fortive Corporation、Anderson Products、Cantel Medical 和 Steris PLC。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場促進因素
    • 交叉感染的風險增加
    • 手術數量增加
    • 製藥和生物技術產業的成長
  • 市場限制因素
    • 與設備相關的高成本
    • 接觸設備中的化學品
  • 波特五力分析
    • 新進入者的威脅
    • 買家/消費者的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度

第5章市場區隔

  • 按設備
    • 高溫滅菌
      • 濕/蒸氣滅菌
      • 乾燥滅菌
    • 低溫滅菌
      • 環氧乙烷 (ETO)
      • 過氧化氫
      • 臭氧
      • 其他低溫滅菌器
    • 過濾除菌
    • 放射線殺菌
      • 電子束滅菌
      • 伽瑪射線滅菌
      • 其他電離放射線殺菌設備
  • 按最終用戶
    • 醫院和診所
    • 製藥和生物技術公司
    • 教育/研究機構
    • 食品和飲料業
    • 其他最終用戶
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區
    • 中東/非洲
      • GCC
      • 南非
      • 其他中東和非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區

第6章 競爭形勢

  • 公司簡介
    • Fortive Corporation（Advanced Sterilization Products）
    • Anderson Products
    • Metall Zug Group（Belimed）
    • Cantel Medical
    • Getinge AB
    • Matachana Group
    • MMM Group
    • STERIS PLC
    • Systec GmbH
    • Stryker Corporation（TSO3 INC.）

第7章 市場機會及未來趨勢

簡介目錄
Product Code: 66760

The Global Sterilization Equipment Market size is estimated at USD 8.94 billion in 2024, and is expected to reach USD 12.77 billion by 2029, growing at a CAGR of 7.37% during the forecast period (2024-2029).

Global Sterilization Equipment - Market

The COVID-19 pandemic has altered healthcare priorities, adversely impacting healthcare management. In the initial days of the pandemic, several countries were in lockdown. They suspended trade with other countries and implemented travel restrictions, leading to a decline in healthcare services such as treatments, diagnosis, and surgical procedures in the first half of 2020. Preventing hospital-acquired infections is a critical aspect of the clinical management of COVID-19, as hospital-acquired infections have been a common feature of such outbreaks. According to the study titled 'Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave', published in August 2021, 11.3% of patients with COVID-19 in 314 UK hospitals became infected after hospital admission. This rate increased to 15.8% in May 2020. Thus, the outbreak has impacted the healthcare facilities' ability to manage hospital-acquired infections, significantly increasing the demand for sterilizers. Due to the rising COVID-19 cases, government associations also worked toward reducing the COVID-19 impact. For instance, as per a March 2020 update by the US Food and Drug Administration (USFDA), Guidance for Industry and Food and Drug Administration Staff, it is adequate to maintain the supply of sterilizers, disinfectant devices, and air purifiers that can facilitate the rapid turnaround of sterilized or disinfected medical equipment and help reduce the risk of viral exposure for patients and healthcare providers to SARS-CoV-2 for public health emergency during the COVID-19 pandemic. The USFDA believes that the policy outlined will help address these urgent public health concerns by increasing the availability of sterilizers, disinfectant devices, and air purifiers during this public health emergency.

With the growing global population, the prevalence of various infectious diseases has rapidly increased. Many of these diseases require medical interventions and surgeries. The instruments and devices used in the surgeries need to be sterilized. Moreover, the infected instruments may give rise to the cross-transmission of diseases. According to the National Plastic Surgery Statistics 2020 by the American Society of Plastic Surgeons, 2,314720 cosmetic surgical procedures were performed in the United States in 2020, and 2,678,302 surgeries were performed in 2019. Additionally, the total number of reconstructive procedures performed in 2020 and 2019 were 6,878,486 and 6,652,591, respectively, in the United States. As these surgeries require sterilized instruments, the market is expected to witness significant growth in the coming years.

These factors have given rise to the need for sterilization equipment to prevent the further spread of infectious diseases. The expansion of pharmaceutical companies has also been a major factor in the market's growth. However, stringent regulatory standards for approval, production of these devices, and disadvantages of chemical agents used as chemical sterilants in some equipment, which may cause potential damage to the eyes and skin, have been restraining the market's growth.

Sterilization Equipment Market Trends

High-temperature Sterilization Equipment Dominates the Market

High-temperature equipment is the most widely used and the most dependable sterilization equipment. High-temperature sterilization is usually nontoxic to patients, staff, and the environment and is highly microbicidal. It also penetrates deep into the medical devices and is less costly than other sterilization equipment, thus making it cost-effective. These factors are responsible for the dominance of this segment in the market. High-temperature sterilization equipment is further sub-segmented into steam sterilization and dry sterilization.

The increasing number of several surgical procedures is boosting the high-temperature sterilization of surgical devices used in the process, which may drive the segment's growth. As per the American Joint Replacement Registry's Annual Report 2020, 1,897,050 primary and revision hip and knee arthroplasty procedures were performed between 2012 and 2019 in the United States. About 995,410 total knee arthroplasty and 625,097 total hip arthroplasty were also performed from 2012 to 2019 in the United States.

According to the American Society for Metabolic and Bariatric Surgery Statistics, around 256,000 surgeries and 252,000 surgeries were performed in 2019 and 2018, respectively, in the United States alone. These statistics show an increase in the number of bariatric surgeries, which is driving the growth of the overall market.

Moreover, the launch of new products in the segment may drive the market's growth. For instance, in May 2020, Esco launched Esco CelCulture CO2 Incubator with High Heat Sterilization (CCL-HHS). It has proven effective in killing resistant fungi, bacterial spore, and vegetative cells that may contaminate the workspace. Thus, such factors are expected to boost the segment's growth during the forecast period.

North America to Witness the Fastest Growth

North America experienced positive growth in the sterilization equipment market, and it is estimated to witness significant growth over the forecast period. The increasing risk of cross-contamination and hospital-acquired infections, rising number of surgeries, the presence of major market players, and growth in R&D procedures are expected to drive the market in the region. The United States is expected to dominate the North American market.

According to the '2020 HAI Progress Report Executive Summary' report published by the Centers for Disease Control and Prevention, approximately one in 31 US patients contract at least one hospital-acquired infection, highlighting the need for improvements in patient care practices in the country's healthcare facilities. Thus, hospital-acquired infections in the country are driving the need for proper hygiene maintenance and sterilization, including timely changing of hospital curtains.

In addition, the elderly population is prone to surgeries and is at higher risk of infections due to a weakened immune system. According to the World Ageing Report 2019, the country's elderly population is expected to increase from 53.340 million in 2019 to 83.813 million in 2050, thus increasing the incidence of infectious diseases and contributing to the market's growth.

The technological advancements in the field are also driving the market. For instance, in September 2020, Midmark Corporation launched the new Sterilizer Data Logger and the updated Midmark M3 Steam Sterilizer, bringing speed, simplicity, and compliance to instrument processing in dental practices in the United States.

Hence, there has been a surge in demand for medical devices and other instruments, increasing the demand for sterilization equipment.

Sterilization Equipment Industry Overview

The majority of sterilization equipment is being manufactured by global players. Market leaders with more funds for research and a better distribution system established their positions in the market. Major market players are Getinge AB, Fortive Corporation, Anderson Products, Cantel Medical, and Steris PLC.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Risks of Cross-transmission
    • 4.2.2 Increasing Number of Surgical Procedures
    • 4.2.3 Growth in Pharmaceutical and Biotechnology Industries
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with the Device
    • 4.3.2 Exposure to Chemicals in Equipments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Equipment
    • 5.1.1 High-temperature Sterilization
      • 5.1.1.1 Wet/Steam Sterilization
      • 5.1.1.2 Dry Sterilization
    • 5.1.2 Low-temperature Sterilization
      • 5.1.2.1 Ethylene Oxide (ETO)
      • 5.1.2.2 Hydrogen Peroxide
      • 5.1.2.3 Ozone
      • 5.1.2.4 Other Low-temperature Sterilization Equipment
    • 5.1.3 Filtration Sterilization
    • 5.1.4 Ionizing Radiation Sterilization
      • 5.1.4.1 E-beam Radiation Sterilization
      • 5.1.4.2 Gamma Sterilization
      • 5.1.4.3 Other Ionizing Radiation Sterilization Equipment
  • 5.2 By End User
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Pharmaceutical and Biotechnology Companies
    • 5.2.3 Education and Research Institutes
    • 5.2.4 Food and Beverage Industries
    • 5.2.5 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Fortive Corporation (Advanced Sterilization Products)
    • 6.1.2 Anderson Products
    • 6.1.3 Metall Zug Group (Belimed)
    • 6.1.4 Cantel Medical
    • 6.1.5 Getinge AB
    • 6.1.6 Matachana Group
    • 6.1.7 MMM Group
    • 6.1.8 STERIS PLC
    • 6.1.9 Systec GmbH
    • 6.1.10 Stryker Corporation (TSO3 INC.)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS